Delivery Order SPE2DR25D2205-SPE2DR26F1M10
- Not listed
- The Defense Logistics Agency awarded a $11,028.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, with an ultimate completion date of October 27, 2025. This non-set-aside competitive award was issued on October 24, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. SHINGRIX is a recombinant zoster (shingles) vaccine indicated for the prevention of herpes zoster and related complications in adults age 50 and older,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, valued at $1,139.18, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. SHINGRIX is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in adults and represents a...
- The Defense Logistics Agency awarded a delivery order valued at $10,533.22 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for prevention of herpes zoster (shingles) and post-herpetic neuralgia in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,389.57 to supply Shingrix vial kits with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a critical pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,918.75 to AmerisourceBergen Drug Corp for Shingrix vial kits, with performance completion targeted for November 19, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster and related...
- The Defense Logistics Agency (DLA) awarded a $11,411.67 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster (shingles) in adults aged 50 and older, making this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits with a ceiling value of $1,139.18. This firm fixed-price contract, which was competitively awarded without a set-aside designation, has an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine commonly procured for military and veteran healthcare systems to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,783.60 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a...
- The Defense Logistics Agency awarded a $7,791.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of September 23, 2025. This non-set-aside contract represents a single delivery order fulfillment awarded on September 22, 2025, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster and its...
- The Defense Logistics Agency awarded a delivery order for Shingrix vial kits to AmerisourceBergen Drug Corp on November 14, 2025, with a ceiling value of $1,102.87 and an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used to prevent shingles and is a critical pharmaceutical supply for...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1M10Delivery Order
The Defense Logistics Agency awarded a $13,071.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, with an ultimate completion date of December 5, 2025. This non-set-aside contract represents a competitively awarded procurement executed on December 4, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. SHINGRIX is a recombinant zoster vaccine indicated for prevention of herpes zoster (shingles) in adults, making this procurement part of the Defense Health Agency's broader vaccine and immunization support requirements for military and veteran populations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals, vaccines, medical supplies, and other healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with the DLA and serves as a critical vendor for military medical supply chain operations, including support to the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 12/3/25 |